The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration.
about
The Androgen Receptor Bridges Stem Cell-Associated Signaling Nodes in Prostate Stem CellsProstate cancer stem cells: the role of androgen and estrogen receptorsImmune responses to human cancer stem-like cells/cancer-initiating cellsInsights into Chemoresistance of Prostate CancerAndrogen receptor and prostate cancer stem cells: biological mechanisms and clinical implicationsMolecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancersCancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistanceNeuroendocrine differentiation in prostate cancer: a mechanism of radioresistance and treatment failureCancer stem cells and exosome signalingMolecular classification of prostate cancer progression: foundation for marker-driven treatment of prostate cancerTumor cells positive and negative for the common cancer stem cell markers are capable of initiating tumor growth and generating both progeniesCell-of-Origin of Cancer versus Cancer Stem Cells: Assays and InterpretationsConcise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding QuestionsNanog1 in NTERA-2 and recombinant NanogP8 from somatic cancer cells adopt multiple protein conformations and migrate at multiple M.W speciesThe combination of the prodrugs perforin-CEBPD and perforin-granzyme B efficiently enhances the activation of caspase signaling and kills prostate cancer.Molecular pathways and targets in prostate cancerCD49f is an efficient marker of monolayer- and spheroid colony-forming cells of the benign and malignant human prostateProstate epithelial stem and progenitor cells.The role of epithelial plasticity in prostate cancer dissemination and treatment resistanceTargeting metastasis-initiating cells through the fatty acid receptor CD36.Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance.Dissociated primary human prostate cancer cells coinjected with the immortalized Hs5 bone marrow stromal cells generate undifferentiated tumors in NOD/SCID-γ mice.Early human prostate adenocarcinomas harbor androgen-independent cancer cellsPrognostic value of cancer stem cell marker aldehyde dehydrogenase in ovarian cancer: a meta-analysisClonogenicity: holoclones and meroclones contain stem cellsFibroblast-Derived Exosomes Contribute to Chemoresistance through Priming Cancer Stem Cells in Colorectal Cancer.Targeted therapy against cancer stem cells.Longitudinal tracking of subpopulation dynamics and molecular changes during LNCaP cell castration and identification of inhibitors that could target the PSA-/lo castration-resistant cells.Loss of androgen receptor expression promotes a stem-like cell phenotype in prostate cancer through STAT3 signaling.BMI-1 Targeting Interferes with Patient-Derived Tumor-Initiating Cell Survival and Tumor Growth in Prostate Cancer.Context dependent regulatory patterns of the androgen receptor and androgen receptor target genesTLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells.CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations.Cancer stem cells and cell size: A causal link?Imaging Reporters for Proteasome Activity Identify Tumor- and Metastasis-Initiating Cells.Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells.Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer.Evaluation of an epithelial plasticity biomarker panel in men with localized prostate cancer.Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer.New insights into prostate cancer stem cells
P2860
Q26765892-77157F39-1424-4F43-A02D-315EEA23B930Q26778415-508F3316-EB84-47D8-9065-B237BA4CF51CQ26781794-A72E091F-6EE5-469F-A225-FE4AB03B9A20Q26795589-BF68E8E7-E9E9-4A04-B532-A45CBAFD770EQ26797063-6F780A0E-E695-4EAD-AF39-44027E375948Q26822406-DA97DB22-9F4B-4881-B7B2-36E741338E97Q26829987-97E34455-DCC4-49D5-9137-246C855ABF15Q26859201-DB28218C-6288-489B-952D-4935DA9CC107Q27013625-BDE7711C-D25E-4CE6-A572-DCB11CCC05CFQ27024775-E3AD510F-FFAA-44E8-9C75-5E286DA2615BQ27318628-EDA2663B-110D-45A9-AA73-AB4428322AA9Q28080701-3FA14278-A062-41B8-8271-CC616B364FCFQ28088370-69744A2F-3C25-4E26-9D08-F9B44CDB2858Q28540510-F27DAC06-0CB8-4C4A-A889-6E2DE4DA8DF7Q33720126-D3E6A1B0-94DF-4888-9C56-42FB87B4F83CQ34365632-FF08AC6F-A52A-4736-960A-E7AC3683EBC9Q34447710-44EECAF0-1B98-4CF4-9B0D-B5DBDF4A187BQ34448228-9A3169B4-1D01-4D52-B36D-65F5103B89BBQ34505037-3CFD4A9A-59F9-461A-A3BB-C5418D6ECFDAQ34547374-6D5CE6A4-FD23-4279-82B7-40495085123BQ34550412-56C2991A-8925-4D01-B509-829F6E2A6A53Q34602712-F9EF44E2-3FEE-4A0C-8503-81A7B2C2A45EQ35005020-8AA63EE8-A6C0-459F-B2C1-8AF41C25A5D3Q35055205-A2E738E1-2B5C-4EBF-9EF6-DDE70BBA17FAQ35108180-AE27C713-D67B-432C-839D-1125316C880DQ35566486-9B3BD35E-3187-4AE8-AAC1-9EDA07BE47A3Q35802983-6DC63441-4609-4089-8740-7FE43BA2B8CFQ35922320-F4A85888-DC2C-4BF9-B42A-D7003B6CFE55Q35963362-38955E03-F1DA-42CE-B015-5D33F2F7B21CQ36053741-F2DB9372-E37F-4FB4-8B63-3A580FE3E502Q36067956-F4A67B6D-BFE0-44B1-9AB4-696B49F15635Q36232040-B14924C6-63F8-4417-AE2B-E61B6094C5FCQ36260616-138960B1-2ADA-47B4-94FA-420E7E042728Q36296444-F2B03272-5B3B-4BC5-966E-BE050FDAD0C8Q36330255-33CB6A10-2638-4769-9187-BB69FCC6CE04Q36414352-6153E7E5-B47E-4B1E-BE6E-E3D8810E1695Q36535407-788110D4-B73A-4C13-955A-3DAC8009240CQ36563715-83506743-3CBC-4DDC-89E7-A827688996C3Q36637412-905E1D0A-FC38-499F-B23B-3A70AC683AD7Q36674318-450AE5BE-839E-4335-9FE7-8550248C5B13
P2860
The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The PSA(-/lo) prostate cancer ...... g cells that resist castration
@nl
The PSA(-/lo) prostate cancer ...... cells that resist castration.
@ast
The PSA(-/lo) prostate cancer ...... cells that resist castration.
@en
type
label
The PSA(-/lo) prostate cancer ...... g cells that resist castration
@nl
The PSA(-/lo) prostate cancer ...... cells that resist castration.
@ast
The PSA(-/lo) prostate cancer ...... cells that resist castration.
@en
prefLabel
The PSA(-/lo) prostate cancer ...... g cells that resist castration
@nl
The PSA(-/lo) prostate cancer ...... cells that resist castration.
@ast
The PSA(-/lo) prostate cancer ...... cells that resist castration.
@en
P2093
P2860
P3181
P1433
P1476
The PSA(-/lo) prostate cancer ...... cells that resist castration.
@en
P2093
Brian Laffin
Collene R Jeter
Dean G Tang
Ganesh S Palapattu
Grace Choy
Hangwen Li
Ivan Ivanov
Jiaoti Huang
Jichao Qin
P2860
P304
P3181
P356
10.1016/J.STEM.2012.03.009
P407
P577
2012-05-01T00:00:00Z